Copies of Astellas Pharma Inc.‘s Myrbetriq ER proposed by Ascent Pharmaceuticals Inc. infringe four patents for the overactive-bladder drug, a federal judge ruled, delaying their launch until 2030.

There are certain medications and surgeries that can help overactive bladder, depending on the cause of the issue, but there are other options as well. Lifestyle changes, exercises, herbal treatments, ...

A US pelvic health expert has urged people to ditch this unnecessary - and possibly detrimental - act.

In a recent video, Dr Madhu Chopra showcased a self-administered Botox procedure to combat facial drooping and explained how ...

A menopause specialist breaks down everything to know about the new treatment ...

Published in Diseases of the Colon & Rectum, the peer-reviewed study found clinically meaningful symptom reduction, high user engagement, and significant pelvic floor improvements in a real-world ...

OnabotulinumtoxinA shows a consistent safety profile in adults treated for chronic migraine and at least 1 other indication.

Astellas Pharma has awarded its healthcare provider (HCP) and direct-to-consumer (DTC) business to CMI Media Group, Compas and WPP Media, the drugmaker confirmed Monday afternoon. According to ...

There are few things worse than falling into a deep sleep only to find yourself awake and staring at the ceiling at 2 a.m.

For five decades, scientists have known about a notorious cancer-causing enzyme called SRC. But they always assumed it only ...